Chinese
Japan
English
ProBio and Neoletix Announce Successful Completion of 200-Liter GMP Production Runs of Recombinant Coagulation FVIII Based on a Novel Production Technology
Through strategic collaboration with ProBio, Initium Therapeutics plans to utilize ProBio’s Berkeley Lights Beacon platform to expand their antibody drug pipeline.
Serving a Rising Power
ProBio Chinese Brand Unveiled, CDMO Capacity Upgraded
ProBio Wins Bioprocessing Excellence in CDMO Services from IMAPAC - ProBio
ProBio Congratulates XLifeSc on FDA Allowance of IND Application for TCR-T Program - ProBio
ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc. - ProBio
ProBio American Commercial Head, Kenneth Lee gives interview to The Medicine Maker about How we can help customers optimize their developing and manufacturing processes - ProBio
Beroni Group Signs Agreement with ProBio to Conduct Further Study to Develop Nanobody-based Medical Solution for COVID-19 - ProBio
GenScript launches CDMO segment ProBio at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum - ProBio
GenScript and Selecxine Enter Into Strategic Cooperation Agreement - ProBio
China's Largest Plasmid and Virus Facility from GenScript was Put into Operation - ProBio
GenScript-Thermo Fisher Strategic Partnership on Life Sciences and Biopharma - ProBio
GenScript Biotech's Biologics R&D and Production Center is Formally Put Into Operation - ProBio
Chinese CDMO GenScript starts construction of GenScript-Legend Biotech Commercial Manufacturing Center - ProBio